Public health context for nutrigenomics and personalized nutrition

Nutrigenomics and Nutrigenetics in Functional Foods and Personalized Nutrition

Volumn , Issue , 2016, Pages 375-397

  Marchlewicz, Elizabeth H ^a   Peterson, Karen E ^a   Omenn, Gilbert S ^b  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84977465794     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (103)

1. Pollack, H., Eugene Floyd Dubois-a biographical sketch. J Nutr, 1961. 75: pp. 3-6.
2. Huxley, R.R. et al., Nutritional research in World War 2: the Oxford Nutrition Survey and its research potential 50 years later. Br J Nutr, 2000. 84(2): pp. 247-251.
3. Penland, J.G., Dietary Reference Intakes (DRIs)-new dietary guidelines really are new! http://www.ars.usda.gov/News/docs.htm?docid=10870, 2006. Accessed December 21, 2011.
4. FAO, Targeting for nutrition improvement. Nutrition in Agriculture, p. 115 http:// www.fao.org/docrep/004/Y1329E/Y1329E00.HTM, 2001. Agriculture and Consumer Protection Department of FAO. Accessed May 18, 2013.
5. FAO, Fighting hunger and obesity. Agriculture, biosecurity, nutrition and consumer protection department of FAO. http://www.fao.org/ag/magazine/pdf/0602-1.pdf 2006 Accessed May 18, 2013.
6. Darnton-Hill, I., B. Margetts, and R. Deckelbaum, Public health nutrition and genetics: implications for nutrition policy and promotion. Proc Nutr Soc, 2004. 63(1): pp. 173-185.
7. USDA, Dietary Guidelines for Americans, 2010, 2011, Center for Nutrition Policy and Promotion, United States Department of Agriculture: Washington, DC.
8. Ordovas, J.M., The quest for cardiovascular health in the genomic era: nutrigenetics and plasma lipoproteins. Proc Nutr Soc, 2004. 63(1): pp. 145-152.
9. Bustamante, C.D., E.G. Burchard, and F.M. De la Vega, Genomics for the world. Nature, 2011. 475(7355): pp. 163-165.
10. McEvoy, B.P. et al., Human population dispersal "Out of Africa" estimated from linkage disequilibrium and allele frequencies of SNPs. Genome Res, 2011. 21(6): pp. 821-829.
11. Nachman, M.W. and S.L. Crowell, Estimate of the mutation rate per nucleotide in humans. Genetics, 2000. 156: pp. 297-304.
12. Villa, P. et al., Cannibalism in the Neolithic. Science, 1986. 233(4762): pp. 431-437.
13. McClellan, J. and M.C. King, Genetic heterogeneity in human disease. Cell, 2010. 141(2): pp. 210-217.
14. Omenn, G.S., Overview of the symposium on public health significance of genomics and eco-genetics. Annu Rev Public Health, 2010. 31: pp. 1-8.
15. Simopoulos, A.P., Nutrigenetics/nutrigenomics. Annu Rev Public Health, 2010. 31: pp. 53-68.
16. Omenn, G.S., Gene-environment interactions: eco-genetics and toxicogenomics, In Genomic and Personalized Medicine, 2nd Ed., G.S. Ginsburg and H. Willard, Editors. In Press, Academic Press: Burlington, MA.
17. Perry, G.H. et al., Diet and the evolution of human amylase gene copy number variation. Nat Genet, 2007. 39: pp. 1256-1260.
18. Chavez, A. and M. Munoz de Chavez, Nutrigenomics in public health nutrition: shortterm perspectives. Eur J Clin Nutr, 2003. 57(Suppl 1): pp. S97-S100.
19. Popkin, B.M., The nutrition transition and obesity in the developing world. J Nutr, 2001. 131(3): pp. 871S-873S.
20. Cordain, L. et al., Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr, 2005. 81(2): pp. 341-354.
21. Omenn, G.S., Evolution and public health. Proc Natl Acad Sci USA, 2010. 107(Suppl 1): pp. 1702-1709.
22. Phillips, C.M. et al., Leptin receptor polymorphisms interact with polyunsaturated fatty acids to augment risk of insulin resistance and metabolic syndrome in adults. J Nutr, 2010. 140(2): pp. 238-244.
23. Hetherington, M.M. and J.E. Cecil, Gene-environment interactions in obesity. Forum Nutr, 2010. 63: pp. 195-203.
24. Pratley, R.E., Gene-environment interactions in the pathogenesis of type 2 diabetes mellitus: lessons learned from the Pima Indians. Proc Nutr Soc, 1998. 57: pp. 175-181.
25. Schultz, L.O. et al., Effects of traditional and Western environments on prevalence of type 2 diabetes in Pima Indians in Mexico and the U.S. Diabetes Care, 2006. 29: pp. 1866-1871.
26. McVean, G., C. Spencer, and R. Chaix, Perspectives on human genetic variation from the HapMap project. PLos Genet, 2005. 1: p. e54.
27. Li, D. et al., Influence of CYP3A5 and MDR1 genetic polymorphisms on urinary 6 beta-hydroxycortisol/cortisol ratio after grapefruit juice intake in healthy Chinese. J Clin Pharmacol, 2010. 50: pp. 775-784.
28. So, H.C. et al., Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases. Genet Epidemiol, 2011. 35: pp. 310-317.
29. Wood, A.R. et al., Allelic heterogeneity and more detailed analyses of known loci explain additional phenotypic variation and reveal complex patterns of association. Hum Mol Genet, 2011. 15: pp. 4082-4092.
30. Davey Smith, G., Use of genetic markers and gene-diet interactions for interrogating population-level causal influences of diet on health. Genes Nutr, 2011. 6: pp. 27-43.
31. Thomas, D., Methods for investigating gene-environment interactions in candidate pathway and genome-wide association studies. Annu Rev Public Health, 2010. 31: pp. 21-36.
32. Thomas, D., Gene-environment-wide association studies: emerging approaches. Nat Rev Genet, 2010. 11(4): pp. 259-272.
33. Smith, A.D., Y.I. Kim, and H. Refsum, Is folic acid good for everyone? Am J Clin Nutr, 2008. 87: pp. 517-533.
34. Yajnik, C.S. and U.S. Deshmukh, Maternal nutrition, intrauterine programming and consequential risks in the offspring. Rev Endocr Metab Disord, 2008. 9: pp. 203-211.
35. Lumley, J. et al., Modeling the potential impact of population-wide periconceptional folate/multivitamin supplementation on multiple births. BJOG, 2001. 108: pp. 937-942.
36. CDC, Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep, 1992. 41: pp. 1-7.
37. Honein, M.A. et al., Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA, 2001. 285: pp. 2981-2986.
38. De Wals, P. et al., Trend in prevalence of neural tube defects in Quebec. Birth Defects Res A Clin Mol Teratol, 2003. 67: pp. 919-923.
39. Godwin, K.A. et al., Changes in frequencies of select congenital anomalies since the onset of folic acid fortification in a Canadian birth defect registry. Can J Public Health, 2008. 99: pp. 271-275.
40. Ray, J.G. et al., Association between folic acid food fortification and congenital orofacial clefts. J Pediatr, 2003. 143: pp. 805-807.
41. Sayed, A.R. et al., Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. Birth Defects Res A Clin Mol Teratol, 2008. 82: pp. 211-216.
42. Roberfroid, D. et al., Effects of maternal multiple micronutrient supplementation on fetal growth: a double-blind randomized controlled trial in rural Burkina Faso. Am J Clin Nutr, 2008. 88: pp. 1330-1340.
43. Garantziotis, S. and D.A. Schwartz, Ecogenomics of respiratory diseases of public health significance. Ann Rev Public Health, 2010. 31: pp. 37-51.
44. Pilsner, J.R. et al., Maternal MTHFR genotype and haplotype predict deficits in early cognitive development in a lead-exposed birth cohort in Mexico City. Am J Clin Nutr, 2010. 92: pp. 226-234.
45. Eidelman, R. et al., Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med, 2004. 164: pp. 1552-1556.
46. Group, H.P.S.C., MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet, 2002. 360(9326): pp. 23-33.
47. Khaw, K.T. et al., Relation between plasma ascorbic acid and morality in men and women in EPIC-Norfolk prospective study: a prospective population study. Lancet, 2001. 357: pp. 657-663.
48. Rimm, E.B. et al., Vitamin E consumption and the risk of coronary disease in men. N Engl J Med, 1993. 328: pp. 1450-1456.
49. Stampfer, M.J. et al., Vitamin E consumption and the risk of coronary disease in women. N Engl J Med, 1993. 328: pp. 1444-1449.
50. Omenn, G.S. et al., Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med, 1996. 334: pp. 1150-1155.
51. Goodman, G.E. et al., The beta-carotene and retinol efficacy trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J Natl Cancer Inst, 2004. 96: pp. 1743-1750.
52. Group, A.-T.B.C.C.P.S., The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med, 1994. 330(15): pp. 1029-1035.
53. Omenn, G.S., Chemoprevention of lung cancer: the rise and demise of beta carotene. Ann Rev Public Health, 1998. 19: pp. 73-99.
54. D'Ambrosio, D., R. Clugston, and W. Blaner, Vitamin A metabolism: an update. Nutrients, 2011. 3: pp. 63-103.
55. Borel, P., Genetic variations involved in interindividual variability in carotenoid status. Mol Nutr Food Res, 2012. 56: pp. 228-240.
56. Lietz, G. et al., Single nucleotide polymorphisms upstream from the beta-carotene 15,15'-monoxygenase gene influence provitamin A conversion efficiency in female volunteers. J Nutr, 2012. 142(1): pp. 161S-165S.
57. Borel, P. et al., Human fasting plasma concentrations of vitamin E and carotenoids, and their association with genetic variants in apo C-III, cholesteryl ester transfer protein, hepatic lipase, intestinal fatty acid binding protein and microsomal triacylglycerol transfer protein. Br J Nutr, 2009. 101(5): pp. 680-687.
58. Borel, P. et al., Human plasma levels of vitamin E and carotenoids are associated with genetic polymorphisms in genes involved in lipid metabolism. J Nutr, 2007. 137(12): pp. 2653-2659.
59. Herberth, B. et al., The lipoprotein lipase serine 447 stop polymorphism is associated with altered serum carotenoid concentrations in the Stanislas Family Study. J Am Coll Nutr, 2007. 26: pp. 655-662.
60. Mondul, A.M. et al., Genome-wide association study of circulating retinol levels. Hum Mol Genet, 2011. 20(23): pp. 4724-4731.
61. Klein, E.A. et al., Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA, 2011. 306(14): pp. 1549-1556.
62. Micheel, C., S. Nass, and G.S. Omenn, Evolution of translational omics: Lessons learned and path forward. http://www.iom.edu/Reports/2012/Evolution-of-Translational-Omics. aspx, 2012, National Academy Press: Washington, DC Accessed December 21, 2012.
63. Voight, B.F. et al., Plasma HDL cholesterol and risk of myocardial infarction: a Mend-elian randomization study. Lancet, 2012. 380(9841): pp. 572-580.
64. Zhang, J. et al., Trends in mortality from cancers of the breast, colon, prostate, esophagus, and stomach in East Asia: role of nutrition transition. Eur J Cancer Prev, 2012. 21(5): pp. 480-489.
65. Crous-Bou, M. et al., Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer. Mutagenesis, 2012. 27: pp. 169-176.
66. Gorham, E.D. et al., Optimal vitamin D status for colorectal cancer prevention: a quantitative meta-analysis. Am J Prev Med, 2007. 32: pp. 210-216.
67. Slattery, M.L. et al., Associations between BMI, energy intake, energy expenditure, VDR genotype and colon and rectal cancers (United States). Cancer Causes Control, 2004. 15: pp. 863-872.
68. Wong, H.L. et al., Vitamin D receptor start codon polymorphism and colorectal cancer risk: modification by dietary calcium and fat in Singapore Chinese. Carcinogenesis, 2003. 24: pp. 1091-1095.
69. Davis, C. and J. Milner, Nutrigenomics, vitamin D, and cancer prevention. J Nutrigenet Nutrigenomics, 2011. 4: pp. 1-11.
70. Powell, E.E., J.R. Jonsson, and A.D. Clouston, Steatosis: co-factor in other liver diseases. Hepatology, 2005. 42: pp. 5-13.
71. Schwimmer, J.B. et al., Prevalence of fatty liver in children and adolescents. Pediatrics, 2006. 118: pp. 1388-1393.
72. Speliotes, E.K. et al., Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLOS Genet, 2011. 7: p. e1001324.
73. Huang, Y. et al., A feed-forward loop amplifies nutritional regulation of PNPLA3. Proc Natl Acad Sci USA, 2010. 107: pp. 7892-7897.
74. Rae-Whitcombe, S.M. et al., Regulation of the promoter region of the human adiponec-tin/PNPLA3 gene by glucose and insulin. Biochem Biophys Res Commun, 2010. 402: pp. 767-772.
75. Moldes, M. et al., Adiponutrin gene is regulated by insulin and glucose in human adipose tissue. Eur J Endocrinol, 2006. 155: pp. 461-468.
76. Sevastianova, K. et al., Genetic variation in PNPLA3 (adiponectin) confers sensitivity to weight loss-induced decrease in liver fat in humans. Am J Clin Nutr, 2011. 94: pp. 104-111.
77. CDC. National Health andNutrition Examination Survey (NHANES): Questionnaires, datasets, and related documentation. http://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm, 2011. Accessed January 26, 2012.
78. Bennett, D. et al., Study protocol: the empirical investigation of methods to correct for measurement error in biobanks with dietary assessment. BMC Med Res Methodol, 2011. 11: pp. 135-139.
79. Freedman, L.S. et al., Dealing with dietary measurement error in nutritional cohort studies. J Natl Cancer Inst, 2011. 103: pp. 1086-1092.
80. Preis, S.R. et al., Application of a repeat-measure biomarker measurement error model to 2 validation studies: examination of the effect of within-person variation in biomarker measurements. Am J Epidemiol, 2011. 173: pp. 683-694.
81. Souverein, O.W. et al., Comparing four methods to estimate usual intake distributions. Euro J Clin Nutr, 2011. 65: pp. S92-S101.
82. Kikunaga, S. et al., The application of a handheld personal digital assistant with camera and mobile phone card (Wellnavi) to the general population in a dietary survey. J Nutr Sci Vitaminol (Tokyo), 2007. 53: pp. 109-116.
83. Gravel, S. et al., Demographic history and rare allele sharing among human populations. Proc Natl Acad Sci USA, 2011. 108(29): pp. 11983-11988.
84. McCabe-Sellers, B. et al., Personalizing nutrigenomics research through community based participatory research and omics technologies. OMICS, 2008. 12(4): pp. 263-272.
85. McCarthy, M.I. and J.N. Hirschhorn, Genome-wide association studies: potential next steps on a genetic journey. Hum Mol Genet, 2010. 17: pp. R156-R165.
86. Cohen, J. et al., Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Proc Natl Acad Sci USA, 2006. 103: pp. 1810-1815.
87. Fahmi, S. et al., Functional characterization of genetic variants in NPC1L1 supports the sequencing extremes strategy to identify complex trait genes. Hum Mol Genet, 2008. 17: pp. 2101-2107.
88. Coventry, A. et al., Deep resequencing reveals excess rare recent variants consistent with explosive population growth. Nat Commun, 2010. 1: p. 131.
89. Marth, G.T. et al., The functional spectrum of low-frequency coding variation. Genome Biol, 2011. 12(9): p. R84.
90. Kaput, J. et al., The case for strategic international alliances to harness nutritional genomics for public and personal health. Br J Nutr, 2005. 94(5): pp. 623-632.
91. CDC. Human Genome Epidemiology Network (HuGE Net). http://www.cdc.gov/genomics/ hugenet/, 2011. Accessed January 18, 2012.
92. NHGRI. The ENCODE Project: ENCyclopedia Of DNA Elements. http://www.genome.gov/10005107, 2011 Accessed January 18, 2012.
93. 1000 Genomes: A deep catalog of human genetic variation. http://www.1000genomes.org/home, 2010. Accessed January 18, 2012.
94. Mosher, M.J. et al. Sex-specific interaction between APOE genotype and carbohydrate intake affects plasma HDL-C levels: the Strong Heart Family Study. Genes Nutr, 2008. 3(2): pp. 87-97.
95. Consortium, W.T.C.C., Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 2007. 447(7145): pp. 661-678.
96. Panagiotou, O.A., E. Evangelou, and J.P. Ioannidis, Genome-wide significant associations for variants with minor allele frequency of 5% or less-an overview: a HuGE review. Am J Epidemiol, 2010. 172(8): pp. 869-889.
97. Fischer, J. et al., Inactivation of the FTO gene protects from obesity. Nature, 2009. 458: pp. 894-898.
98. Frayling, T. et al., A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science, 2007. 316: pp. 889-894.
99. Speakman, J., D.M. Jackson, and A.M. Johnstone, Polymorphisms of the FTO gene are associated with variation in energy intake but not energy expenditure. Obesity, 2008. 16: pp. 1961-1965.
100. Khoury, M.J. et al., Beyond base pairs to bedside: a population perspective on how genomics can improve health. Am J Public Health, 2011. 102: pp. 34-37.
101. Feero, W., A. Guttmacher, and F. Collins, The genome gets personal-almost. JAMA, 2008. 299: pp. 1351-1352.
102. McBride, C.M. et al., The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors? Annu Rev Public Health, 2010. 31: pp. 89-103.
103. Lovegrove, J.A. and R. Gitau, Nutrigenetics and CVD: what does the future hold? Proc Nutr Soc, 2008. 67(2): pp. 206-213.